MWNA
DGX icon

Marshall Wace North America’s Quest Diagnostics DGX Stock Holding History

Marshall Wace North America’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$951K Sell
6,541
-47,448
-88% -$6.94M ﹤0.01% 943
2021
Q2 		$7.12M Buy
53,989
+40,573
+302% +$5.31M 0.03% 450
2021
Q1 		$1.72M Sell
13,416
-80,922
-86% -$9.97M 0.01% 875
2020
Q4 		$11.2M Buy
94,338
+88,858
+1,621% +$10.8M 0.05% 354
2020
Q3 		$627K Sell
5,480
-478,514
-99% -$56.5M ﹤0.01% 918
2020
Q2 		$55.2M Sell
483,994
-724,663
-60% -$76.9M 0.36% 75
2020
Q1 		$97.1M Sell
1,208,657
-1,063,782
-47% -$110M 0.74% 32
2019
Q4 		$243M Buy
2,272,439
+216,327
+11% +$22.6M 1.17% 17
2019
Q3 		$220M Buy
2,056,112
+275,530
+15% +$28.3M 1.25% 11
2019
Q2 		$181M Buy
1,780,582
+448,332
+34% +$43.1M 1.13% 18
2019
Q1 		$120M Sell
1,332,250
-235,820
-15% -$20.4M 0.85% 25
2018
Q4 		$131M Sell
1,568,070
-524,796
-25% -$49.2M 1.26% 15
2018
Q3 		$226M Sell
2,092,866
-565,264
-21% -$62M 1.55% 13
2018
Q2 		$292M Buy
2,658,130
+214,446
+9% +$22.3M 1.65% 3
2018
Q1 		$245M Buy
2,443,684
+586,085
+32% +$60M 1.23% 7
2017
Q4 		$183M Buy
1,857,599
+1,700,001
+1,079% +$161M 1.01% 9
2017
Q3 		$14.8M Sell
157,598
-599,886
-79% -$63.7M 0.09% 276
2017
Q2 		$84.1M Buy
757,484
+330
+0% +$34.9K 0.61% 26
2017
Q1 		$74.2M Buy
+757,154
New +$72.2M 0.59% 31
2013
Q3 		– Sell
-4,698
Closed -$285K – 627
2013
Q2 		$285K Buy
+4,698
New +$280K 0.02% 368

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Marshall Wace North America's DGX Position: Q3 2021 in Review

Marshall Wace North America reduced its Quest Diagnostics (DGX) stake by 88% in Q3 2021, selling an estimated $6.94M and leaving 6,541 shares worth $951K. The position accounts for ﹤0.01% of the portfolio, ranked #943.

Marshall Wace North America first reported a position in DGX in Q2 2013 and has held it in 20 quarters since. The position peaked at $292M in Q2 2018. 838 funds tracked by Wall St. Rank hold DGX as of Q3 2021.

  • Marshall Wace North America held 6,541 shares of Quest Diagnostics worth $951K as of Q3 2021.
  • Marshall Wace North America sold 47,448 Quest Diagnostics shares in Q3 2021, an estimated $6.94M.
  • Quest Diagnostics made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #943 holding.
  • Marshall Wace North America first reported a position in Quest Diagnostics in Q2 2013 and has held it in 20 quarters since.
  • Marshall Wace North America's Quest Diagnostics position peaked at $292M in Q2 2018.
  • 838 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.